ICE Regimen for Relapsed/Refractory Bone and Soft Tissue Sarcomas in Children

AYDIN, GÜZİDE; AKYÜZ, CANAN; VARAN, ALİ; YALÇIN, BİLGEHAN; KURUCU, NİLGÜN; Kutluk, Tezer

doi:10.2174/1574887113666180124114818

ICE Regimen for Relapsed/Refractory Bone and Soft Tissue Sarcomas in Children

AYDIN G. B., AKYÜZ C., VARAN A., YALÇIN B., KURUCU N., Kutluk T.

REVIEWS ON RECENT CLINICAL TRIALS, cilt.13, sa.2, ss.126-131, 2018 (ESCI, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 13 Sayı: 2
Basım Tarihi: 2018
Doi Numarası: 10.2174/1574887113666180124114818
Dergi Adı: REVIEWS ON RECENT CLINICAL TRIALS
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
Sayfa Sayıları: ss.126-131
Hacettepe Üniversitesi Adresli: Evet

Özet

Background: The outcome of bone and soft tissue sarcomas (BST) after relapse has very poor prognosis with survival rates less than 39%. Unfortunately there are not many treatment options, but promising responses have been reported with ifosfamide, etoposide and carboplatin (ICE).